acclimate
发表于 2025-3-28 18:03:43
http://reply.papertrans.cn/23/2234/223361/223361_41.png
cardiopulmonary
发表于 2025-3-28 20:33:18
http://reply.papertrans.cn/23/2234/223361/223361_42.png
arboretum
发表于 2025-3-29 00:38:28
Cervical Cancer Cytology and Pathology,al/vaginal cytology, including recommendations for a proper cytologic report. Furthermore, the main cytologic criteria used in the diagnosis of squamous and glandular invasive cervical neoplasia precursor lesions are included. In the final part of the cytology section, some advantages and drawbacks
capsaicin
发表于 2025-3-29 05:27:32
http://reply.papertrans.cn/23/2234/223361/223361_44.png
类人猿
发表于 2025-3-29 10:22:37
Imaging in Cervical Cancer,tion of Gynecology and Obstetrics (FIGO) criteria, cancer staging systems have been shown to be deficient for the examination of prognostic factors of CC, including tumor size and infiltration of the parametria or pelvic wall, as well as for the evaluation of nodal metastases. In this regard, imagin
Accessible
发表于 2025-3-29 11:55:42
http://reply.papertrans.cn/23/2234/223361/223361_46.png
GIDDY
发表于 2025-3-29 18:10:22
Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer,nding on the survival disease-free, the site and size of recurrence can be set 5-year survivals of 48–60%. Since it was first reported in 1948, pelvic exenteration has been used in the treatment of advanced pelvic cancers. The original procedure has been modified in an attempt to preserve urinary or
canvass
发表于 2025-3-29 21:19:26
http://reply.papertrans.cn/23/2234/223361/223361_48.png
内行
发表于 2025-3-30 00:32:03
http://reply.papertrans.cn/23/2234/223361/223361_49.png
expound
发表于 2025-3-30 04:02:04
Immuno-Oncology in Cervical Cancer,une-mediated treatments, or immuno-oncology, currently represent 6% of cancer therapies, and in the next 10 years, this percentage is expected to increase up to 70%. There are ongoing efforts to develop specific immunotherapies, such as immunomodulatory drugs and antibodies, to treat CC in combinati